25 related articles for article (PubMed ID: 14682141)
1. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation.
Prokopiou S; Moros EG; Poleszczuk J; Caudell J; Torres-Roca JF; Latifi K; Lee JK; Myerson R; Harrison LB; Enderling H
Radiat Oncol; 2015 Jul; 10():159. PubMed ID: 26227259
[TBL] [Abstract][Full Text] [Related]
2. [Choice of fractionation regimen in radiotherapy of inoperable esophageal cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM
Vopr Onkol; 2003; 49(5):651-6. PubMed ID: 14682142
[TBL] [Abstract][Full Text] [Related]
3. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
Pemberton LS; Din OS; Fisher PM; Hatton MQ
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
[TBL] [Abstract][Full Text] [Related]
4. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer.
Bettington CS; Tripcony L; Bryant G; Hickey B; Pratt G; Fay M
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):105-12. PubMed ID: 23374562
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
7. [Accelerated fractionation regimens in radiotherapy of inoperable non-small-cell lung cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM; Kudriavtsev LV; Akishin VA
Vopr Onkol; 2003; 49(5):647-51. PubMed ID: 14682141
[TBL] [Abstract][Full Text] [Related]
8. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
9. [Altered fractionation].
Hasegawa M; Nishio M; Myoujin M; Nishiyama N; Ichimura W
Gan To Kagaku Ryoho; 2006 Apr; 33(4):428-35. PubMed ID: 16612149
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer.
Dahele M; Brade A; Pearson S; Bezjak A
CMAJ; 2009 Jun; 180(13):1326-8. PubMed ID: 19546457
[No Abstract] [Full Text] [Related]
11. Altered fractionation radiotherapy in lung cancer.
Palazzi M; Cerrotta A; Villa S
Tumori; 1998; 84(2):171-5. PubMed ID: 9620242
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer: are we out of step?
Gregor A; Macbeth F
Clin Oncol (R Coll Radiol); 1995; 7(1):2-3. PubMed ID: 7727301
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
